|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12,379.00 GBX | -1.83% |
|
-13.56% | -9.96% |
| 10:23am | AstraZeneca Licenses Zegfrovy From Dizal in Up to $1.5 Billion Deal | MT |
| 10:10am | European Midday Briefing : Shares Fall, Oil Hits One-Month High on Middle East Tensions | DJ |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASTRAZENECA PLC | Other Pharmaceuticals | -1.55% | -13.56% | -9.96% | +16.45% | +43.22% | 262B |  | |  |
- Stock Market
- Stocks
- AZN Stock
- Charts AstraZeneca PLC
- Comparison Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
